Literature DB >> 28236153

Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.

Nuket Eliyatkin1, Safiye Aktas2, Gulden Diniz3, Halil Hakan Ozgur4, Zubeyde Yildirim Ekin5, Ali Kupelioglu4.   

Abstract

Caveolin-1 (Cav-1) is well known as a principal scaffolding protein of caveolae which are specialized plasma membrane structures. The role of Cav-1 in tumorigenesis of breast cancers is relatively less studied. The aim of the present study is to describe the biological roles of Cav-1 in breast cancers considering its contrasting dual functions as an oncogene and as a tumor suppressor. This study included 71 females with breast cancer who had been histopathologically diagnosed in Private Gunes Pathology Laboratory between the years 2007, and 2012. The mean age is 52.48 ± 12.8 years. Patients were followed up for a mean period of 47.97 ± 20.48 months. We didn't determine Cav-1 positive tumor cells. In 36 cases (50.7%), there were stromal expressions of Cav-1. In the statistical analysis, there was a statistically significant correlation between Cav-1 expression and ER (p = 0.033), metastasis (p = 0.005), lymphatic invasion (p = 0.000), nodal metastasis (p = 0,003), perinodal invasion (p = 0.003), metastasis (p = 0.005) and survival (p = 0.009). We found that Cav-1 expression is associated with tumor size, histological grade, lymph node involvement. Accordingly, we have suggested that Cav-1 may be a predictive biomarker for breast cancer.

Entities:  

Keywords:  Breast cancer; Caveolin 1; Predictive biomarker

Mesh:

Substances:

Year:  2017        PMID: 28236153     DOI: 10.1007/s12253-017-0212-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

Review 1.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

2.  Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.

Authors:  A F Hurlstone; G Reid; J R Reeves; J Fraser; G Strathdee; M Rahilly; E K Parkinson; D M Black
Journal:  Oncogene       Date:  1999-03-11       Impact factor: 9.867

Review 3.  Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer.

Authors:  Wang Shan-Wei; Xu Kan-Lun; Ruan Shu-Qin; Zhao Li-Li; Chen Li-Rong
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

4.  Elevated expression of caveolin is associated with prostate and breast cancer.

Authors:  G Yang; L D Truong; T L Timme; C Ren; T M Wheeler; S H Park; Y Nasu; C H Bangma; M W Kattan; P T Scardino; T C Thompson
Journal:  Clin Cancer Res       Date:  1998-08       Impact factor: 12.531

Review 5.  "Omics" of HER2-positive breast cancer.

Authors:  Valentina Bravatà; Francesco Paolo Cammarata; Giusi Irma Forte; Luigi Minafra
Journal:  OMICS       Date:  2013-02-19

6.  Expression of caveolin-1 in peritumoral stroma is associated with histological grade in ovarian serous tumors.

Authors:  Sevil Sayhan; Gulden Diniz; Tugba Karadeniz; Duygu Ayaz; Dudu Solakoglu Kahraman; Mehmet Gokcu; Hulya Tosun Yildirim
Journal:  Ginekol Pol       Date:  2015-06       Impact factor: 1.232

7.  Stromal cell expression of caveolin-1 predicts outcome in breast cancer.

Authors:  Erica K Sloan; Daniel R Ciocca; Normand Pouliot; Anthony Natoli; Christina Restall; Michael A Henderson; Mariel A Fanelli; Fernando D Cuello-Carrión; Francisco E Gago; Robin L Anderson
Journal:  Am J Pathol       Date:  2009-05-01       Impact factor: 4.307

8.  Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.

Authors:  Moumita Chatterjee; Edgar Ben-Josef; Dafydd G Thomas; Meredith A Morgan; Mark M Zalupski; Gazala Khan; Charles Andrew Robinson; Kent A Griffith; Ching-Shih Chen; Thomas Ludwig; Tanios Bekaii-Saab; Arnab Chakravarti; Terence M Williams
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

9.  Genotyping analysis and ¹⁸FDG uptake in breast cancer patients: a preliminary research.

Authors:  Valentina Bravatà; Alessandro Stefano; Francesco P Cammarata; Luigi Minafra; Giorgio Russo; Stefania Nicolosi; Sabina Pulizzi; Cecilia Gelfi; Maria C Gilardi; Cristina Messa
Journal:  J Exp Clin Cancer Res       Date:  2013-04-30

Review 10.  Molecular markers for breast cancer: prediction on tumor behavior.

Authors:  Bruna Karina Banin Hirata; Julie Massayo Maeda Oda; Roberta Losi Guembarovski; Carolina Batista Ariza; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe
Journal:  Dis Markers       Date:  2014-01-28       Impact factor: 3.434

View more
  11 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis.

Authors:  Mee Rie Sheen; Jennifer L Fields; Brian Northan; Judith Lacoste; Lay-Hong Ang; Steven Fiering
Journal:  Elife       Date:  2019-12-17       Impact factor: 8.140

3.  Tissue Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Breast Cancers.

Authors:  Gülden Diniz; Ayşe Gül Pulular; Dudu Solakoğlu Kahraman; Umut Varol; Sevil Sayhan; Duygu Ayaz; Cem Karaali
Journal:  Eur J Breast Health       Date:  2022-10-01

Review 4.  The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy.

Authors:  Yaojie Fu; Shanshan Liu; Shanghelin Yin; Weihong Niu; Wei Xiong; Ming Tan; Guiyuan Li; Ming Zhou
Journal:  Oncotarget       Date:  2017-05-25

5.  Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.

Authors:  Yuyang Zeng; Mengxi Chen; Sridha Ganesh; Shunze Hu; Honglei Chen
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

6.  New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes.

Authors:  Cristian Scatena; Giovanni Fanelli; Giuseppe Nicolò Fanelli; Michele Menicagli; Paolo Aretini; Valerio Ortenzi; Sara Piera Civitelli; Lorenzo Innocenti; Federica Sotgia; Michael P Lisanti; Antonio Giuseppe Naccarato
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

7.  Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients.

Authors:  Alessandro Bittoni; Riccardo Giampieri; Federica Pecci; Giada Pinterpe; Alessandra Mandolesi; Michela Del Prete; Antonio Zizzi; Sonia Crocetti; Carolina Liguori; Giulia Mentrasti; Luca Cantini; Chiara Pellei; Renato Bisonni; Marina Scarpelli; Rossana Berardi
Journal:  Curr Oncol       Date:  2021-09-09       Impact factor: 3.677

Review 8.  Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes.

Authors:  Joshua D Greenlee; Tejas Subramanian; Kevin Liu; Michael R King
Journal:  Cancer Res       Date:  2020-09-30       Impact factor: 13.312

9.  Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.

Authors:  H A Zielinska; J M P Holly; A Bahl; C M Perks
Journal:  Cancer Lett       Date:  2018-01-11       Impact factor: 8.679

10.  Caveolin-1 is a prognostic marker and suppresses the proliferation of breast cancer.

Authors:  Liping Ren; Peijuan Zhou; Huajia Wu; Yuqi Liang; Rui Xu; Hai Lu; Qianjun Chen
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.